Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Pfizer and BioNTech’s Comirnaty Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

(BUSINESS WIRE) August 27, 2025 -- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”)...

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration...

Travere Therapeutics Announces U.S. FDA Approves REMS Modification for Filspari (sparsentan) in IgA Nephropathy

(BUSINESS WIRE) August 27, 2025 -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Toxic Algae in Lakes Can Kill Pets Within Minutes, Expert Warns

SUNDAY, Aug. 31, 2025 — As people enjoy the waning days of summer outdoors, a Virginia Tech veterinary expert reminds pet owners about a potentially...

Monthly News Roundup - August 2025

Wegovy Granted Accelerated Approval as First GLP-1 Treatment for the Treatment of MASH Novo Nordisk’s Wegovy (semaglutide) has received US Food...

Labor Day Mission: Build Social Ties Through Live Events

SATURDAY, Aug. 30, 2025 — If your social life has been lived out in Zoom calls since the height of the pandemic, Labor Day weekend is prime time...

Baxdrostat Demonstrated Statistically Significant and Clinically Meaningful Reduction in Systolic Blood Pressure in Patients with Hard-to-Control Hypertension in the BaxHTN Phase III Trial

Positive full results from the ​BaxHTN Phase III trial showed ​baxdrostat demonstrated a statistically significant and clinically meaningful reduction...

FDA Now Providing Daily Updates on Adverse Events

 The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system. In...

Older Age, Lower Fitness Linked to Atrial Ectopic Burden

Age is a significant independent risk factor for atrial ectopic burden (AEB) and ventricular ectopic burden (VEB), according to a study presented at the...

Geriatric Assessment in the Emergency Department Reduces Admission Rates

A comprehensive assessment of older adults being seen in the emergency department can help reduce hospital admissions, according to a study published online...

2010 to 2023 Saw Decline in Births, Increase in Deaths in the United States

From 2010 to 2023, the number of births in the United States declined, and the number of deaths increased, according to the Aug. 27 National Vital Statistics...

At Least 95 Sickened in Salmonella Outbreak Linked To Recalled Eggs

FRIDAY, Aug. 29, 2025 — At least 95 people in 14 states have been sickened in a salmonella outbreak tied to recalled eggs, federal health officials...

Common Pain Meds, Acetaminophen and Ibuprofen, Could Be Contributing To Antibiotic Resistance

FRIDAY, Aug. 29, 2025 — Common over-the counter painkillers might be quietly fueling antibiotic resistance, a new study warns. Ibuprofen and acetaminophen...

FDA Removes Risk Evaluation and Mitigation Strategy (REMS) Program for the Antipsychotic Drug Clozapine

FDA Removes Risk Evaluation and Mitigation Strategies (REMS) Program for the Antipsychotic Drug Clozapine Neutropenia Risk Remains, but REMS No Longer...

Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling

August 27, 2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets...

Regeneron Announces Positive Results from Phase 3 Trial of Cemdisiran in Generalized Myasthenia Gravis

 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the primary and key secondary endpoints were met in the Phase 3 NIMBLE trial...

Read more news...

Recently Added

Recently added consumer and prescribing information: Cyklx, Papzimeos, Brinsupri, Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Dawnzera Dawnzera (donidalorsen) is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary...
  • Tonmya Tonmya (cyclobenzaprine hydrochloride) is a sublingual formulation of cyclobenzaprine hydrochloride indicated for the treatment of...
  • Papzimeos Papzimeos (zopapogene imadenovec-drba) is a non-replicating adenoviral vector-based immunotherapy indicated for the treatment of adults...

More FDA approvals